综合多组学识别了MCRS1作为一个因果枢纽,将衰老,代谢综合征和乳腺癌进展联系起来
Yiying Tao1, Xibing Ding1, Wei Xuan1
1Key Laboratory of Anesthesiology (Shanghai Jiao Tong University, Ministry of Education), Department of Anesthesiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
International journal of surgery (London, England)
|January 20, 2026
概括
衰老和代谢综合征 (MetS) 与乳腺癌 (BC) 有关. 这项研究确定了MCRS1作为一个关键的基因因果连接这些条件,提供一个潜在的治疗点BC与代谢问题.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 代谢研究研究 代谢研究
背景情况:
- 衰老和代谢综合征 (MetS) 是乳腺癌 (BC) 的确立危险因素.
- 关联衰老,MetS和BC的分子机制仍然不太清楚.
- 识别核心分子连接对于理解这些情况下的BC病原体至关重要.
研究的目的:
- 为了识别和验证一个中心分子驱动器在老化,MetS和BC的交叉点.
- 确定候选基因在BC发育中的因果作用.
- 探索已识别的分子点的治疗潜力.
主要方法:
- 来自BC,MetS和老化队伍的综合转录基因数据.
- 采用机器学习来识别核心基因签名.
- 利用门德尔的随机化进行因果推断和单细胞RNA测序进行表征.
- 进行了体外和体内临床前验证研究.
主要成果:
- 确定了25个基因的签名,共同的BC,MetS和衰老.
- 蒸了五个枢纽基因的签名,形成了一个准确的诊断名录.
- 确立了MCRS1作为BC的唯一因果风险因素.
- MCRS1驱动癌细胞的增殖,细胞循环,衰老和代谢重编程.
- 在体内,MCRS1的遗传淘汰抑制了BC细胞的增殖和瘤的生长.
结论:
- MCRS1被确定为一个中心的分子枢纽,因果地将衰老和MetS与BC联系起来.
- MCRS1是经过验证的BC进展的驱动因素,也是一个有前途的生物标志物.
- MCRS1代表了BC的潜在治疗标,特别是在具有代谢并发病症的患者中.
相关概念视频
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:21Causality in Epidemiology
1.5K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.5K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
198
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
198
00:52What is Metabolism?
131.2K
Overview
131.2K
02:04Covalently Linked Protein Regulators
8.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.7K
01:28Criteria for Causality: Bradford Hill Criteria - II
1.2K
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
1.2K